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Marcel Deckert,* Sophie Tartare-Deckert,†‡ increased tyrosine phosphorylation and activation of a
number of cellular proteins and downstream effectorsCle´ment Couture,*§ Tomas Mustelin,*
(DeFranco, 1995; Mustelin, 1994; Weiss and Littman,and Amnon Altman*
1994).*Division of Cell Biology
The central role of Syk family PTKs in both develop-La Jolla Institute for Allergy and Immunology
mental and activation events in hematopoietic cells wasSan Diego, California 92121
recently demonstrated by genetic studies (Arpaia et al.,† INSERM Unite´ 145
1994; Chan et al., 1994; Cheng et al., 1995; Elder et al.,Faculte´ de Me´decine
1994; Negishi et al., 1995; Turner et al., 1995). The p72syk06107 Nice, Cedex 2
(Syk) PTKis widely expressed in hematopoietic cells andFrance
was found to associate either constitutively or inducibly
with the BCR, TCR, and Fc receptor. Syk-deficient mice
exhibit a block in B cell development, most likely dueSummary
to a defect in signaling through the pre-BCR complex
(Cheng et al., 1995; Turner et al., 1995). A related PTK,Syk family kinases are essential for lymphocyte devel-
p70zap (Zap) is expressed in T and natural killer cells,opment and activation. Therefore the identification of
and its absence in humans causes a severe combinedtheir direct effectors is of critical importance. Here,
immunodeficiency characterized by the failure of CD41we report that Syk interacts in the yeast two-hybrid
T cells to respond to antigen stimulation and by ansystem with Vav, a proto-oncogene product exclu-
absence of peripheral CD81 T cells (Arpaia et al., 1994).sively expressed in hematopoietic cells. This interac-
Antigen receptor triggering leads to activation andtion was direct, required the catalytic activity of Syk,
tyrosine phosphorylation of Zap and Syk, leading tothe SH2 domain of Vav, and tyrosine residues in the
additional SH2-mediated interactions with Src familylinker domain of Syk. Vav also associated with Syk
PTKs (Couture et al., 1994; Thome et al., 1995), andand Zap in antigen receptor–stimulated B or T cells,
cotransfection experiments have demonstrated a func-respectively. Functionally, Vav was phosphorylated by
tional cooperation between these two families of PTKs.Syk family kinases both in vivo and in vitro. Further-
However, Syk, but not Zap, was shown to be active inmore, Syk and Vav cooperated to activate NF-AT syn-
the absence of Src family kinases in COS cells, humanergistically. These results indicate that the interaction
cytotoxic T lymphocytes, and mast cells (Couture et al.,between Syk family kinases and Vav plays an impor-
1994; Kolanus et al., 1993; Rivera and Brugge, 1995).tant role in coupling immune recognition receptors
This suggests that Syk can directly associate with orto signaling pathways involved in lymphokine pro-
phosphorylate (or both) critical effector proteins. Pres-duction.
ently, however, little is known about the physiological
substrates of Syk and Zap. Syk family PTKs are required
for the activation of phospholipase C-g (PLC-g), and theIntroduction
SH2 domain of PLC-g can interact with phosphotyrosyl
(PTyr) residues located in the linker domain of Syk, be-Clonotypic T and B cell antigen receptors (TCR and
tween the tandem SH2 and catalytic domains (Law et al.,BCR, respectively) and receptors for the Fc fragment
1996; Sillman and Monroe, 1995). Tyrosine-containingof immunoglobulins are associated noncovalently with
synthetic peptides based on the sequence of two hema-conserved transmembrane proteins that transduce acti-
topoietic-specific signaling proteins, p95vav (Vav) andvation signals. The cytoplasmic tails of these signaling
HS1, were recently shown to serve as good substratessubunits contain at least one immunoreceptor tyrosine-
for purified Syk in vitro (Brunati et al., 1995).based activation motif (ITAM) critical for signal trans-
Vav contains several functional domains, including aduction (Cambier, 1995; Reth, 1989). Based on current
Dbl homology (DH) domain, a Pleckstrin homology (PH)genetic and biochemical studies, it is believed that im-
domain, a cysteine-rich domain, one SH2 domain, andmunoreceptor-initiated hematopoietic cell activation re-
two SH3 domains. Triggering of structurally diverse he-sults from the sequential activation of protein tyrosine
matopoietic receptors, including antigen receptors, Fc,kinases (PTKs) of the Src and Syk families and their
cytokine, and PTK receptors, induces rapid phosphory-
interaction with phosphorylated ITAMs. Src family ki-
lation of Vav on tyrosine (reviewed by Bonnefoy-Be´rard
nases (Lck, Fyn, or both in T cells) are thought to induce
et al., 1996). The SH2 domain of Vav was found toassoci-
the early tyrosine phosphorylation of the ITAMs, which
ate with ligand-activated epidermal growth factor recep-
leads to the recruitment of Syk family PTKs via their
tors in Vav-transfected fibroblasts (Bustelo et al., 1992;
tandem Src homology 2 (SH2) domains. This process
Margolis et al., 1992), with Zap in TCR-activated Jurkat
induces the activation of Syk family PTKs and leads to
cells (Katzav et al., 1994), and with the recently cloned
(Jackman et al., 1995) protein SLP-76 (Motto et al., 1996;‡Present address: The Salk Institute, Peptide Biology Laboratory,
Wu et al., 1996). Although the exact function of Vav10010 North Torrey Pines Road, La Jolla, California 92037.
in hematopoietic cells is unclear, it is likely to play an§Present address: The Terry Fox Molecular Oncology Group, Lady
important role in immune cell signaling pathways. Thus,Davis Institute for Medical Research, Jewish General Hospital, Mon-
treal, Qc H3T1E2, Canada. vav2/2 mice display a severe reduction in the number
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Figure 1. Interaction between Syk or Zap and
Various Signaling Proteins in Yeast
(A) Yeast (L40) was cotransformed with the
plasmids encoding LexA–Syk or LexA–Zap in
combination with plasmids encoding the indi-
cated GAD hybrids. After isolation on selec-
tion medium, transformants were assayed for
b-galactosidase activity using a filter assay
as described in Experimental Procedures. As
a negative control, the Syk and Zap hybrids
were coexpressed with GAD alone. The inter-
action between GAD–Raf and LexA–RasV12 is
also shown as a positive control (Votjek et
al., 1993). A positive interaction of Syk with
p85, Vav, and Lck SH2 is shown. Similar re-
sults were obtained by analyzing yeast
growth on selective plates lacking histidine.
(B) LexA–Zap and LexA–Syk expression and
phosphorylation in yeast. We lysed 2 3 108
yeast expressing LexA–Zap or LexA–Syk hy-
brids. The lysates were immunoprecipitated
using anti-Zap or anti-Syk antibodies and an-
alyzed by anti-PTyr (top) or anti-Zap (bottom)
immunoblotting.
and antigen receptor–mediated activation of both ma- the LexA DNA-binding domain (LDB) and the full-length
sequence of Zap or Syk (LexA–Zap or LexA–Syk, respec-ture T and B cells (Fischer et al., 1995; Tarakhovsky et
al., 1995; Zhang etal., 1995). In addition, Vav overexpres- tively). The second partner was a Gal4 activation domain
(GAD) fusion with the full-length sequences of Raf (GAD–sion in T cells enhances activation of transcriptional
elements in the interleukin-2 (IL-2) promoter (Holsinger Raf; Votjek et al., 1993), Grb2, the regulatory subunit
(p85) of phosphatidylinositol 3-kinase, Shc, Vav, the tan-et al., 1995; Wu et al., 1995), and Vav cooperates with
SLP-76 to induce IL-2 gene activation (Motto et al., 1996; dem SH2 domains of PTP2C (Tartare-Deckert et al.,
1995, 1996), or the SH2 domain of Lck. The yeast strainWu et al., 1996).
In this study, we addressed the potential interaction L40 was cotransformed with combinations of these hy-
brids, and their interaction was monitored by the expres-of Syk and Zap with downstream effectors involved in
immune cell activation using the yeast two-hybrid sys- sion of two reporter genes, HIS3 and LacZ, which con-
tain upstream LexA-binding sites (Votjek et al., 1993).tem and biochemical analysis of T and B cells. We found
the following: first, Syk interacts with Vav in the yeast The LexA–Syk and LexA–Zap hybrids were incapable
by themselves, or in combination with an unrelated GADtwo-hybrid system; second, the interaction between Syk
and Vav is direct, depends on the catalytic activity of fusion protein (i.e., GAD–lamin), of activating the expres-
sion of the two reporter genes (data not shown). Co-Syk, and involves the SH2 domain of Vav and tyrosine
residue(s) located in a region of Syk between its transformation of LexA–Zap with any of the GAD hybrids
failed to induce b-galactosidase expression (Figure 1A),C-terminal SH2 (SH2[C]) and kinase domains; third, Vav
binds Syk and Zap in BCR- or TCR-stimulated B and T even though the LexA–Zap fusion protein was readily
expressed in yeast (Figure 1B, bottom). By contrast, thecells, respectively, demonstrating that this interaction
also occurs under physiological conditions; and, fourth, coexpression of LexA–Syk with GAD–p85, GAD–Vav, or
GAD–Lck SH2 induced b-galactosidase expression (Fig-Vav is phosphorylated by Syk and Zap in vivo and in
vitro, and coexpression of Vav and Syk results in in- ure 1A) and enabled yeast growth in the absence of
histidine (data not shown). The discrepancy betweencreased activation of NF-AT in T cells. These results
identify Vav as a direct physical and functional target Syk and Zap correlated with theability of the two kinases
to become autophosphorylated. Thus, Syk, but not Zap,for Syk family kinases, suggesting that this association
is critical for both BCR- and TCR-mediated immune cell was phosphorylated on tyrosine (Figure 1B, top). We
conclude that Syk interacts in yeast with Vav, p85,activation.
and Lck.
Characterization of the InteractionResults
between Syk and Vav
To study the Syk–Vav interaction in more detail, we firstSyk Binds Vav, Lck, and p85 in Yeast
We have examined the interaction of the two PTKs, Zap determined which domain(s) of Vav interacts with Syk.
Four different GAD–Vav deletion constructs were gener-and Syk, with potential downstream effectors using the
yeast two-hybrid system originally described by Fields ated (Figure 2A): Vav 386–846 contains the PH domain,
the two SH3 and the SH2 domain of Vav; Vav 610–846and Song (1989). One partner was a hybrid between
Syk and Vav Interaction
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Figure 2. Mapping of the Vav Domains Medi-
ating the Interaction with Syk
(A) Schematic representation of the human
full-length Vav protein and truncated Vav
constructs used in this study. DH, Dbl ho-
mology domain; PH, Pleckstrin homology
domain.
(B) Yeast (L40)was cotransformed with LexA–
Syk plus the indicated GAD–Vav constructs.
Coexpression of GAD–Raf with LexA–RasV12
or LexA–lamin B are shown as positive and
negative controls, respectively. b-Galactosi-
dase activity in cell lysates was measured by
a liquid assay using the substrate o-nitrophe-
nyl-b-D-galactopyranoside and was calcu-
lated as described by Miller (1972). Results
are expressed as the mean (6 SD) of three
independent transformants and are repre-
sentative of three similar experiments. Similar
results were obtained by analyzing growth on
selective plates lacking histidine.
consists of the two SH3 and the SH2 domain of Vav; that the interaction between Syk and Vav in yeast re-
quires the SH2 domain of Vav and is most likely stabi-Vav 670–765 corresponds to the SH2 domain of Vav;
and Vav 1–610 comprises the N-terminal region, DH, lized by one or both flanking SH3 domain(s).
Next, we examined whether the interaction betweenPH, and cysteine-rich domains of Vav. The interaction
of these hybrids with LexA–Syk was analyzed by a quan- Syk and Vav was dependent upon the tyrosine kinase
activity of Syk, its SH2 domains, or both. A kinase-inac-titative b-galactosidase assay. The results (Figure 2B)
indicate that, by comparison with full-length Vav, dele- tive hybrid (LexA–Syk K395R) was generated by mutat-
ing a conserved lysine residue (Lys-395) in the ATP-tion of the N-terminal plus DH domains (Vav 386–846)
and, to a larger extent, additional deletion of the PH and binding site of Syk. We also generated three deletion
mutants: Syk 1–298, Syk 1–212, and Syk 213–628 (Figurecysteine-rich domains of Vav (Vav 610–846) increased
the interaction with Syk. Thus, these N-terminal domains 3A). The ability of these mutants to interact with GAD–
Vav 610–846 and GAD–Vav 610–846/R696A was tested.of Vav are not required for the interaction with Syk and,
moreover, appear to contain sequences that interfere Unlike wild-type Syk, LexA–Syk K395R was unable to
interact with Vav (611 6 75 U versus 35 6 3 U, respec-with this interaction. Conversely, a Vav construct con-
taining residues 1–610 but lacking the tandem SH3-SH2- tively) (Figure 3B). As a negative control, it was shown
that both Syk hybrids failed to interact with the SH2-SH3 domains of Vav failed to interact with Syk, indicating
that one or more of these C-terminal domains is involved mutated Vav hybrid (7 6 2 U and 5 6 0.9 U). Consistent
with these results, the two Syk hybrids lacking the kinasein the interaction. A mutation in a conserved arginine
residue within the SH2 domain of Vav (R696L), which is domain but containing all or part of the tandem SH2
domains (Syk 1–298 or Syk 1–212) did not interact withknown to inactivate this domain (Katzav, 1993), abol-
ished the interaction of Vav 610–846 with Syk; con- GAD–Vav 610–846. By contrast, deletion of the two SH2
domains of Syk (Syk 213–628) increased the interactionversely, GAD–Vav 670–765, which contains only the SH2
domain of Vav, still interacted with LexA–Syk, albeit to between LexA–Syk and GAD–Vav 610–846 (1127 6 86 U)
(Figure 3B). These results demonstrate that the catalytica lower extent than the other interacting constructs. The
discrepancy between the strong interaction detected activity of Syk, but not its SH2 domains, is necessary
for its interaction with the Vav SH2 domain.between LexA–Syk and GAD–Vav 610–846 and the rela-
tively modest interaction between LexA–Syk and GAD– Finally, we wished to identify the potential binding site
for the Vav SH2 domain on Syk. The linker region ofVav 670–765 likely results from a difference in theconfor-
mational stability of the two hybrids. Our results indicate Syk located between its SH2(C) and kinase domains
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Figure 3. Mapping of Syk Domains Inter-
acting with Vav
(A) Schematic representation of the human
Zap or porcine Syk proteins and the different
truncated forms of Syk used in this study.
These mutated or deleted Syk constructs are
described in detail in the text. KIN, kinase
(catalytic) domain.
(B) The indicated Zap or Syk LDB hybrids
were assayed for their interaction with GAD–
Vav 610–846 or SH2-mutated GAD–Vav 610–
846/R696A hybrids in yeast. b-Galactosidase
activity in cell lysates was measured as de-
scribed previously. Results are expressed as
the mean (6 SD) of three independent trans-
formants. Similar results were obtained by
analyzing growth on selective plates lacking
histidine.
(C) LDB Syk hybrids mutated at the indicated
tyrosine residues within the Syk linker region
were assayed for their interaction with GAD–
Vav 1–846 in yeast. b-Galactosidase activity
in cell lysates was measured as described
above, and resultsare expressed as the mean
(6 SD) of three independent transformants.
contains a sequence, Tyr-Glu-Ser-Pro, which has been to the SH2 domain of Lck (Couture et al., 1996). The
corresponding fusion protein, LexA–Syk Y518/519F,suggested to represent a binding site for the Vav SH2
domain (Songyang et al., 1994). We mutated the corre- was still capable of interacting with GAD–Vav 610–846,
albeit to a lower degree than wild-type Syk (Figure 3B).sponding tyrosine residue (Tyr-341), an adjacent tyro-
sine residue (Tyr-345), or both and assessed the effect The weaker interaction of this mutant is consistent with
its reduced enzymatic activity (Couture et al., 1996).of these mutations on the interaction with Vav (GAD–Vav
1–846) by a quantitative b-galactosidase assay. The
Y341F mutation nearly abrogated the interaction of Syk
Table 1. Comparison of the Interaction of Vav or Lck with Sykwith Vav (90% inhibition), whereas the Y345F mutation
in the Yeast Two-Hybrid System
decreased this interaction by only 60% (Figure 3C). The
Cotransformation with LDB Hybridsdouble mutation Y341/345F caused a 96% reduction of GAD
this interaction. The relative specificity of the interaction Hybrids Syk Syk K395R Syk Y341F
between Vav and Tyr-341 of Syk is indicated by the
Vav 111 2 2
finding that Syk Y341F was still capable of interacting Vav 670-765 11 2 2
with a GAD hybrid consisting of the Lck SH2 domain Lck 121-224 111 2 1
(Table 1). These results indicate that Tyr-341 and, to a Lck 121-224/Y192E 2 2 2
lesser degree, Tyr-345 within the linker region of Syk The indicated combinations of plasmids encoding GAD–Vav or
are required for binding to the SH2 domain of Vav. GAD–Lck and LDB–Syk hybrids were used to cotransform yeast,
As an additional control, we tested the effect of an- and interactions were detected by a filter b-galactosidase assay.
The results are shown in a semiquantitative manner. An SH2-other mutation in two tandem tyrosine residues in the
mutated Lck construct (Y192E) is included as a negative control.catalytic domain of Syk (Tyr-518 and Tyr-519) on the
This mutation abolishes the binding of Lck SH2 to autophosphory-interaction with Vav. These residues represent the major
lated Syk (Couture et al., 1996).
autophosphorylation site of Syk and mediate its binding
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Figure 4. Interaction of Vav with Syk or Zap in Lymphocytes
(A) Coimmunoprecipitation of Syk with Vav. H2 B cells (5 3 107) were either left unstimulated or were stimulated for 4 min with a F(ab9)2
fragment of a goat anti–human immunoglobulin antibody (10 mg/ml) and lysed as described in Experimental Procedures. Cell lysates were
subjected to immunoprecipitation using anti-Vav antibodies. The immunoprecipitates and whole lysate (2 3 106 cell equivalents) were analyzed
by immunoblotting with the indicated antibodies.
(B) In vitro association of the Vav SH2 domain with B cell proteins. Lysates were prepared from H2 cells (2.5 3 107), which were either left
unstimulated or stimulated as described above. Lysates were then precipitated with the indicated GST–Vav fusion proteins, and bound proteins
or whole lysates (1 3 106 cell equivalents) were probed with anti-PTyr (top) or anti-Syk (bottom) antibodies.
(C) Association of the Vav SH2 domain with Zap and SLP-76 in Jurkat T cells. Jurkat cells (2.5 3 107) were either left unstimulated or stimulated
for 4 min with anti-CD3 (OKT3; 5 mg/ml) and lysed. The lysates were precipitated with GST–Vav fusion proteins, and the bound proteins were
detected by immunoblotting with anti-PTyr (top), anti-Zap (middle), or anti-SLP-76 (bottom) antibodies. PTyr-containing proteins in whole-cell
lysates (1 3 106 cell equivalents) are shown for comparison. The positions of Zap and SLP-76 are indicated by the open arrows.
(D) Lysates from H902-tagged Syk-transfected COS cells were precipitated with control GST or GST–Vav SH2 proteins, and Syk binding was
detected by immunoblotting with anti-PTyr (top) or anti-tag (H902; bottom) MAbs.
Together, these results underscore the critical role of with authentic Vav (Figure 4A). Three additional PTyr-
containing proteins of z72, z62, and z50 kDa wereTyr-341 in the interaction with the Vav SH2 domain.
also detected in Vav immunoprecipitates. Similar phos-
phoproteins were not detected in control (NMS) immu-
Interaction of Syk Kinases with Vav noprecipitates. The tyrosine phosphorylation of the 72
in Lymphocytes and 62kDa proteins was increased following BCR stimu-
We extended our analysis to determine whether the in- lation, whereas the PTyr content of the 50 kDa protein
teraction between Syk and Vav detected in the yeast was similar in resting and activated cells (Figure 4A,
two-hybrid system also occurs in lymphocytes. First, top). When the same immunoprecipitates were immu-
the presence of associated proteins was examined in noblotted with an anti-Syk antibody (Figure 4A, middle),
Vav immunoprecipitates from lysates of resting or BCR- the 72 kDa phosphoprotein comigrated with Syk, indi-
stimulated human B lymphoid (H2) cells. Anti-PTyr im- cating that tyrosine-phosphorylated Syk is associated
munoblotting revealed that BCR stimulation induced the with Vav following B cell activation. The stoichiometry
of Syk association with Vav appeared low (#1%), butphosphorylation of a 95 kDa protein, which comigrated
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was maintained under harsh lysis conditions using RIPA
buffer (data not shown).
To confirm this association more directly, we probed
lysates of BCR-stimulated H2 cells with glutathione
S-transferase (GST) fusion proteins containing the wild-
type SH2 domain of Vav or a mutated counterpart (SH2*)
with the inactivating R696L point mutation. Bound cellu-
lar proteins were detected by immunoblotting with anti-
PTyr (4G10) or anti-Syk antibodies (Figure 4B). Three
major phosphoproteins of 90, 72, and 62 kDa present
in lysates of activated B cells associated with the active
Vav SH2 domain. An additional z160 kDa protein was
also observed after a longer exposure of the membrane
(data not shown). Anti-Syk blotting revealed the associa-
tion of Syk with the GST–Vav SH2 protein, but not (or
very weakly) with GST–Vav SH2* (Figure 4B). Similar
binding of Syk to GST–Vav SH2 was also observed in
lysates of BCR-stimulated Ramos B cells (data not
shown).
Since Vav SH2 can bind the Syk-related Zap kinase
Figure 5. Direct Binding of the Vav SH2 Domain to Syk
in activated T cells (Katzav et al., 1994), we extended
Syk immunoprecipitates were prepared from lysates of COS cells
this analysis to T cells by probing lysates of resting or transfected with vector controls (lane 1), wild-type Syk (lane 2), Syk
anti-CD3-stimulated Jurkat T cells with the GST–Vav Y341F (lane 3), or kinase-deficient Syk K395R (lane 4) using the
SH2 fusion protein and detecting bound cellular proteins H902 MAb. Following SDS–PAGE and transfer to nitrocellulose, the
samples were overlayed with a GST–Vav SH2 fusion protein, andby anti-PTyr immunoblotting (Figure 4C). Activated T
binding was detected with an anti-GST MAb (A) or with anti-phos-cell lysates contained two major Vav SH2–bound 76 and
photyrosine MAb (4G10) (B). A control GST protein tested in parallel70 kDa phosphoproteins. An additional 36 kDa PTyr-
did not bind to Syk (data not shown). In (C) the same membrane
containing protein was also observed in longer expo- was stripped and reprobed with MAb H902 to assess the expression
sures. Reprobing of the same membrane with anti-Zap level of the transfected Syk proteins.
or anti-SLP-76 antibodies demonstrated that the 76 and
70 kDa phosphoproteins comigrated with SLP-76 and
Zap, respectively. SLP-76 is known to associate with Syk proteins correlated with their PTyr content as re-
the SH2 domain of Vav in activated T cells (Motto et al., vealed by anti-PTyr immunoblotting (Figure 5B). The de-
1996; Wu et al., 1996). Immunoblot analysis of H2 or creased tyrosine phosphorylation of Y341F Syk sug-
Ramos B cell lysates showed no detectable expression gests that Tyr-341 is a major autophosphorylation site
of SLP-76. Taken together, these results indicate that or that this residue regulates the enzymatic activity of
association with the Vav SH2 domain is a common prop- Syk (or both). Taken together, these results are consis-
erty of Syk family kinases in activated T and B lympho- tent with the data obtained in the yeast two-hybrid ex-
cytes. periments and demonstrate a similar association be-
Finally, we used the GST–Vav SH2 fusion protein to tween Vav and Syk in lymphocytes.
probe lysates of COS cells transiently transfected with
an epitope-tagged Syk expression vector. Immunoblot- Syk and Zap Phosphorylate Vav
ting with anti-PTyr (4G10) or anti-tag (H902) monoclonal Next, we examined whether the interaction between Syk
antibodies (MAbs) revealed that tyrosine-phosphory- and Vav results in phosphorylation of Vav. COS cells
lated Syk was bound to GST–Vav SH2, but not (or very were transiently transfected with Vav alone or with Vav
weakly) to GST alone (Figure 4D). plus wild-type or mutated Syk expression vectors. Anti-
To determine whether the SH2 domain of Vav binds PTyr immunoblotting of Vav immunoprecipitates from
directly to Syk, we assessed the binding of GST–Vav these cells demonstrated that the PTyr content of Vav
SH2 to Syk by Far Western blotting. Wild-type or mutant was markedly elevated when it was coexpressed with
Syk immunoprecipitates from COS cells were sepa- wild-type, but not with kinase-deficient Syk (Figure 6A,
rated by SDS–polyacrylamide gel electrophoresis (SDS– lane 3 versus lanes 2 and 5). Of note, Vav phosphoryla-
PAGE) and transferred to nitrocellulose membranes. The tion was dramatically decreased when it was coex-
membranes were incubated with a GST–Vav SH2 fusion pressed with the catalytically active Y341F Syk mutant
protein, and binding was detected with an anti-GST (lane 4). These results demonstrate, first, that Vav is
MAb. This analysis revealed binding of GST–Vav SH2 phosphorylated on tyrosine when coexpressed with Syk
to a protein comigrating with authentic Syk in immuno- and, second, that Syk residue Y341 is important for this
precipitates containing wild-type and, to a lesser de- functional interaction.
gree, Y341F-mutated Syk, but not to kinase-inactive Syk To address more directly the possibility that Vav can
K395R (Figure 5A). The identity of the faster-migrating be a physiological substrate for Syk family kinases, we
protein is unknown. When probed with the anti-tag MAb produced a GST fusion protein corresponding to resi-
(H902) all three Syk proteins were found tobe expressed dues 161–191 of Vav, which encompass a potential sin-
at a similar level in the transfected COS cells (Figure gle substrate site for Syk, i.e., Tyr-174 within an Ile-Tyr-
Glu-Asp-Leu motif (Brunati et al., 1995). As a negative5C). The differential binding of Vav SH2 to the different
Syk and Vav Interaction
597
Figure 6. Syk Phosphorylates Vav
(A) Phosphorylation in intact cells. COS cells
were transiently transfected with vector con-
trols (lane 1), Myc-tagged Vav alone (lane 2),
or Vav plus the indicated H902-tagged Syk
expression vectors (lanes 3–5). Cell lysates
were immunoprecipitated with H902 or anti-
Vav antibodies, and the membranes were im-
munoblotted with anti-PTyr (4G10), H902, or
9E10 MAbs as indicated to reveal the PTyr
content of Vav (upper panel) and the expres-
sion levels of Syk (middle panel) or Vav (bot-
tom panel).
(B) In vitro phosphorylation. Wild-type or
Y341F-mutated Syk were immunoprecipi-
tated from COS cells lysates using MAb H902.
We added 5 mg of recombinant GST, GST–
Vav, or GST–Vav Y174F to the washed Syk
immunoprecipitates and performed an in
vitro kinase reaction as described in Experi-
mental Procedures. The samples were sub-
jected to SDS–PAGE analysis and auto-
radiography. The bands corresponding to
autophosphorylated Syk or the phosphory-
lated Vav fusion peptide are indicated.
(C) Syk expression. Lysates of vector control
(lane 1), Syk- (lane 2), or Syk Y341F–
transfectedcells (lane 3) were immunoprecip-
itated with MAb H902 and immunoblotted
with the same antibody.
(D) Phosphorylation of Vav by Syk and Zap.
Syk, Zap, and Lck were immunoprecipitated
from singly transfected COS cells lysates,
and an in vitro kinase reaction was performed
on the individual immunoprecipitates or the
indicated mixtures using GST–Vav as a sub-
strate (left panel). An in vitro kinase reaction
was performed using 1 mg of recombinant
Zap (recZap) and an unmutated or Y174F-
mutated GST–Vav fusion peptide substrates
(right panel). The samples were subjected to
SDS–PAGE analysis and autoradiography.
The band corresponding to the phosphory-
lated Vav fusion peptide is indicated.
control, we used a similar fusion protein in which Tyr- lesser degree (55% by densitometry) than wild-type Syk,
consistent with a potential regulatory role of Tyr-341.174 had been mutated to phenylalanine (Vav Y174F).
These proteins weresubjected to an invitro kinase assay This lower activity is unlikely in itself to explain the much
greater reduction ($90%) in the association betweenusing immunopurified Syk from COS cells. As shown in
Figure 6B, Syk phosphorylated the wild-type Vav fusion Syk Y341F and Vav (Figure 6A).
Finally, we compared the ability of Syk and Zap toprotein. In contrast, GST and GST–Vav Y174F were not
phosphorylated detectably by Syk. The mutated Syk phosphorylate the recombinant Vav protein by per-
forming in vitro kinase assays with immunopurified Syk,Y341F, which was expressed at a similar level (Figure
6C), phosphorylated the recombinant Vav protein to a Zap-70, or Lck from transiently transfected COS cells.
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Figure 7. NF-AT Activation in Syk- or Vav-
Transfected Jurkat Cells (or Both)
(A) Jurkat-TAg cells (10 3 106) were electro-
porated with 5 mg of an NF-AT-Luciferase re-
porter construct in combination with 5 mg of
Myc-tagged pEF-Vav, 5 mg of H902-tagged
wild-type or Y341-mutated Syk, or combina-
tions of Vav plus Syk, as indicated. After 40
hr, 5 3 105 cells were either left unstimulated
or were stimulated for 6 hr with an anti-CD3
MAb (OKT3; 10 mg/ml). Luciferase activity in
cell lysates was determined as described in
Experimental Procedures. Results are repre-
sented as the fold induction of luciferase ac-
tivity as compared with the activity in unstim-
ulated cells transfected with empty vectors.
Results represent the mean of triplicate de-
terminations, and standard deviation of the
mean of each condition was less than 15%.
Results are representative of two indepen-
dent experiments. The basal activity and the
maximum NF-AT responses were appproxi-
mately 20 arbitrary units (AU) and 2 3 104 to
3 3 104 AU, respectively.
(B) Aliquots of cell lysates from each transfec-
tion group were subjected to SDS–PAGE and
immunoblotting with anti-Myc (9E10; upper
panel) or H902 (lower panel) MAbs to assess
the expression levels of the transfected Vav
and Syk proteins, respectively.
We found that Syk or Lck alone, but not Zap, phosphory- luciferase reporter gene (NF-AT-Luc). In unstimulated
cells, transient overexpression of Vav or Syk alone ledlated Vav. Lck synergized with either Zap or Syk to
increase dramatically the phosphorylation of the Vav to a 60- and 90-fold increase in the basal transcriptional
activity of the NF-AT reporter construct, respectivelyfusion peptide (Figure 6D, left panel). Toconfirm that Zap
can directly phosphorylate Vav, we used a baculovirus- (Figure 7A). Coexpression of Syk plus Vav resulted in a
synergystic effect, i.e., a 450-fold activation of NF-AT.derived recombinant Zap protein that is known to be
constitutively active (Isakov et al., 1996). The recombi- This was clearly not due to increased expression of Syk
or Vav (or both) in doubly transfected cells by compari-nant enzyme phosphorylated the Vav fusion protein in
vitro (Figure 6D, right panel). These results indicate that son with cells transfected with Vav or Syk separately
(Figure 7B). The Syk Y341F mutant was considerablyVav is a substrate for Syk family kinases and that Tyr-
174 represents one likely phosphorylation site. less active, either alone or in the presence of coex-
pressed Vav. In anti-CD3-stimulated cells, Vav or Syk
overexpression stimulated NF-AT to a level higher thanSyk and Vav Synergize to Activate NF-AT
in T Cells inunstimulated cells. Sykand Vav coexpressionresulted
in an additive effect, which was no longer observed withTCR stimulation leads to activation of distinct transcrip-
tion factors involved in IL-2 production, including NF- the Y341F Syk mutant. As a control, phorbol myristate
acetate plus ionomycin stimulation caused strong NF-AT (Schreiber and Crabtree, 1992), and transient Vav
overexpression was recently found to result in activation AT stimulation, which was not augmented by transient
Syk or Vav overexpression (data not shown). We alsoof this transcription factor (Holsinger et al., 1995; Wu et
al., 1995). Since Vav is phosphorylated on tyrosine in observed that SH2-mutated Vav (R696L) was incapable
of cooperating with wild-type Syk and neither was ki-activated T cells (Margolis et al., 1992) and our results
(Figures 1–6) demonstrated a physical and functional nase-deficient Syk capable of synergizing with wild-type
Vav to activate NF-AT (data not shown). These findingsSyk–Vav interaction leading to phosphorylation of the
latter, we assessed the effects of transient transfection indicate that Syk and Vav cooperate in stimulating a
signaling pathway leading to NF-AT activation. Thus,with Vav alone, or with Vav plus Syk, on the activity of
an NF-AT transcriptional element cloned upstream of a the interaction between Syk and Vav revealed by our
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earlier experiments has a distinct functional and physio- strong support of our finding, the Vav SH2 domain was
shown to be necessary for efficient phosphorylation oflogically relevant outcome.
Vav induced by TCR stimulation (Wu et al., 1996), pre-
sumably resulting from the binding of Vav to activated
Discussion Zap. A second tyrosine residue (Tyr-345) lies within a
Tyr-Ala-Asp-Pro motif, and mutation of this residue to
Identification of the substrates and downstream ef- phenylalanine caused only partial inhibition of the bind-
fectors of immunoreceptor-associated PTKs of the Src ing to the SH2 domain of Vav, indicating that this residue
and Syk families is essential for elucidating the mecha- may be less critical for that interaction.
nisms of immune cell activation. Although several sub- Although the association between Syk and the SH2
strates of Lck and Fyn have been identified, the physio- domain of Vav was readily demonstrated in yeast, it
logical substrates of Zap or Syk are still unknown. was important to ascertain whether it also occurs in
Nevertheless, genetic studies have recently demon- lymphocytes and, if so, what are its functional conse-
strated a critical role of Syk family PTKs in T or B cell quences. By analyzing the physical and functional inter-
development and function (Arpaia et al., 1994; Chan et actions between Syk and Vav in human B or T cells
al., 1994; Cheng et al., 1995; Elder et al., 1994; Negishi cells, we were able to confirm and extend the findings
et al., 1995; Turner et al., 1995). We have combined two obtained in the yeast two-hybrid system. First, Vav inter-
independent approaches, i.e., the use of the yeast two- acted with Syk or Zap in vivo following BCR or TCR
hybrid system and a biochemical–functional analysis of stimulation, respectively. Second, a Vav SH2 fusion pro-
protein–protein interactions in mammalian cells, includ- tein was capable of binding activated (i.e., tyrosine-
ing T and B cells, to address the interactions between phosphorylated) Syk (and Zap) in vitro, and this binding
Syk family kinases and potential immediate targets. Evi- was direct as demonstrated by Far Western blotting.
dence is presented that the Vav proto-oncogene prod- The undetectable or weak binding of the GST–Vav SH2
uct, as well as Lck and the p85 subunit of the phosphati- fusion protein to catalytically inactive or Y341F-mutated
dylinositol 3-kinase, interact with phosphorylated Syk Syk, respectively, is consistent with our findings in yeast
in yeast. Zap expressed in yeast was not detectably that both intact catalytic activity of Syk and Tyr-341 are
phosphorylated, thus explaining the absence of interac- essential.
tions with the LexA–Zap hybrid. The discrepancy be- A point mutation in the conserved PTyr-binding
tween Syk and Zap most likely reflects their differential pocket of Vav SH2 abolished its binding to Syk or Zap,
mode of activation. While Zap is incapable of autoacti- as well as to other PTyr-containing proteins present in
vating, and requires phosphorylation by Src family ki- activated B or T cell lysates. In this regard, Vav SH2
nases in order to become enzymatically active, Syk can interacted with distinct tyrosine-phosphorylated pro-
become activated by autophosphorylation and can me- teins, including Zap and SLP-76, in lysates of TCR-
diate downstream signaling events in the absence of stimulated Jurkat cells, consistent with recent studies
Src family kinases (Couture et al., 1994; Kolanus et al., (Katzav et al., 1994; Motto et al., 1996; Wu et al., 1996).
1993; Rivera and Brugge, 1995). Consistent with these SLP-76 was recently found to mediate activation of IL-2
findings, human Syk was recently shown to exhibit a gene transcription in T cells in association with Vav
greater intrinsic catalytic activity than Zap (Latour et al., (Motto et al., 1996; Wu et al., 1996). One notable differ-
1996). ence between B and T cells was the absence in the
In the present study, we focused on the interaction former of detectable SLP-76. This probably reflects the
between Vav and Syk. We determined that the SH2 do- finding that B cell lines express very low levels of SLP-
main of Vav is necessary and sufficient for the interaction 76 mRNA compared with T cell lines (Jackman et al.,
with Syk, although one or both SH3 domains most likely 1995). Instead, we observed association of Vav SH2 with
stabilize it. Other domains of Vav appeared to exert a a major 85–90 kDa unidentified B cell phosphoprotein.
negative influence on this interaction. The interaction One possibility is that a family of SLP-76-related proteins
between Syk and Vav was dependent on the catalytic is differentially expressed in distinct hematopoietic cell
activity of Syk, but did not require its SH2 domains. types.
Unlike mutations in three other Syk tyrosine residues Although only a small fraction of cellular Syk associ-
(345, 518, and 519), mutation of Tyr-341, located in the ated with Vav under our lysis conditions, the association
linker domain between its SH2(C) and catalytic domains, was stable as evidenced by its resistance to extensive
almost completly abolished the interaction with Vav. washes in RIPA buffer. This may be due either to a low
Although a formal proof is lacking, this suggests that stoichiometry of phosphorylation at Tyr-341 by Syk or
Syk autophosphorylates on Tyr-341, thereby creating a to a low affinity of the interaction between phospho-
binding site for the Vav SH2 domain. Tyr-341 lies within Tyr-341 and Vav SH2 in vivo. In addition, another SH2-
a motif (Tyr-Glu-Ser-Pro) found tobe optimal for interac- containing effector(s) may compete for binding Syk at
tion with Vav SH2 (Songyang et al., 1994). It has been this phosphorylated residue. This notion is supported
suggested that the same motif, which is repeated twice by a recent report that the equivalent tyrosine residue
in SLP-76, mediates the activation-dependent associa- in human Syk, Tyr-348 (as well as Tyr-352), was required
tion of SLP-76 with theVav SH2 domain (Wu et al., 1996). for the interaction between active Syk and PLC-g1 and
Since this sequence is conserved between human and for subsequent PLC-g1 activation (Law et al., 1996). An-
porcine Syk and Zap (Tyr-315), it is likely that the activa- other likely explanation for this low stoichiometry is that
tion-induced phosphorylation of this tyrosine residue on Vav and Syk dissociate rapidly following the dephos-
phorylation of Syk family kinases by associated SH2-Zap is also important for the binding of Vav to Zap. In
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Figure 8. Putative Model of Sequential Acti-
vation and Recruitment of, and Interactions
among, Syk, Vav, and Lck
As a consequence of immunoreceptor cross-
linking, the phospho-ITAM-bound Syk is acti-
vated and becomes autophosphorylated on
Tyr-518, Tyr-519, and Tyr-341 (and potentially
other residues). Phospho-Tyr-341 recruits
Vav (and PLC-g1) by direct binding to its SH2
domain (Figures 2–5; Table 1), thereby facili-
tating phosphorylation of Vav on Tyr-174 by
activated Syk (Figure 6). This event then cre-
ates a docking site for the SH2 domain of Lck
(or another Src family kinase). The associated
Lck may then phosphorylate additional tyro-
sine residues in the Vav–Syk complex. Inde-
pendently of this mechanism, Lck can also
be recruited via direct association of its SH2
domain with the phosphorylated Tyr-518/519
residues of Syk (Couture et al., 1996). See
text for more details.
containing protein tyrosine phosphatases, which repre- demonstrated, we observed a direct association be-
tween the SH2 domains of Lck or Fyn and tyrosine-sents an important regulatory event during lymphocyte
activation. Indeed, PTyr phosphatase inhibitors can in- phosphorylated Vav from activated T cells (T. Collins
and N. Bonnefoy-Be´rard, unpublished data), and Lckcrease the association between Syk family kinases and
Vav SH2 (Wu et al., 1996; M. D., unpublished data), was found to coimmunoprecipitate with Vav in an activa-
tion-dependent manner (Gupta et al., 1994). Studies inand an association between Zap and the SHP1 PTyr
phosphatase was recently described (Plas et al., 1996). a Syk-deficient chicken B cell lymphoma have indicated
that Syk plays a critical role in coupling the BCR to PLC-What are the functional consequences of the interac-
tion between Syk family kinases and Vav? The present g-dependent events, i.e., inositol phosphate production
and calcium mobilization (Takata et al., 1994). Interest-study addresses two aspects of this important question.
First, we demonstrated increased tyrosine phosphoryla- ingly, deficient Vav phosphorylation is observed in mast
cells from syk2/2 mice triggered via their FceRI (V. Tybul-tion of Vav in COS cells in the presence of coexpressed
wild-type Syk. Not surprisingly, this effect was not ob- ewicz, personal communication). However, these stud-
ies also demonstrated that a cross-talk between Sykserved with catalytically inactive Syk. Of more impor-
tance and interest, this increased phosphorylation was and Lyn, a Src family PTK, was required for optimal
BCR-dependent activation and maximal tyrosine phos-practically abolished by mutating Tyr-341 inSyk, a muta-
tion that reduced its catalytic activity by only z45%. phorylation (Takata et al., 1994). Thus, our findings sug-
gest a potential mechanism for the sequential recruit-This result suggests that recruitment of Vav to phospho-
Tyr-341 is physiologically relevant in that it facilitates ment of Syk and Src family PTKs by Vav, an event that
may facilitate cross-talk between these two PTK familiesthe phosphorylation of Vav by Syk (Figure 8). Although
the results obtained with COS cells do not prove that Vav (Figure 8).
Another clue regarding the biological significance ofis a direct substrate for Syk, this is strongly supported by
our finding that a Vav fusion peptide containing a single the interaction between Syk and Vav comes from the
effects of transient overexpression of Syk or Vav (ortyrosine residue (Tyr-174) was phosphorylated in vitro
by immunopurified Syk. This is consistent with a recent both) in Jurkat cells on the transcriptional activity of NF-
AT, an important element in cytokine gene promotersfinding that a synthetic peptide containing Tyr-174 of
Vav was an efficient substrate for purified Syk in vitro such as IL-2, IL-3, IL-4, and tumor necrosis factor a
(Northrop et al., 1993; Schreiber and Crabtree, 1992;(Brunati et al.,1995). Furthermore, we also observed that
baculovirus-derived recombinant Zap or Lck-activated Rao, 1994). In a similar system, it was recently shown
that Vav activates the IL-2 gene and potentiates activa-Zap (Figure 6D) was similarlycapable of phosphorylating
Tyr-174 inVav, suggesting that Vav isa directphysiologi- tion of the IL-2 promoter induced by TCR/CD3 ligation
(Holsinger et al., 1995; Wu et al., 1995). Our results con-cal target for both Syk and Zap.
One potential consequence of the phosphorylation of firm these findings and extend them by demonstrating
that coexpression of Syk and Vav causes synergisticVav on Tyr-174 by Syk or Zap may be the creation of a
binding site for the SH2 domain of Src family kinases NF-AT activation in the absence of TCR stimulation and
produces an additive effect in anti-CD3-stimulated cells.(Figure 8). The corresponding motif, Tyr-Glu-Asp-Leu,
was found to be optimal for this binding (Songyang et This effect was not observed (or was less pronounced)
when Y341-mutated, but otherwise catalytically active,al., 1993). Although such binding has not been formally
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phosphatase PTP2C have been described previously (Tartare-Deck-Syk was coexpressed with Vav. This finding strongly
ert et al., 1995, 1996).suggests that Tyr-341 is important, in the context of
Plasmid construction, cloning, and DNA sequencing were carriedintact lymphocytes, for an optimal functional interaction
out according to standard protocols (Ausubel et al., 1992). In-frame
betwen these two signaling proteins. Furthermore, the insertion of the desired cDNAs into yeast expression plasmids was
linker domain of Zap exhibit a tyrosine residue (Tyr-315) performed using thermostable PWO polymerase (Boeringher Mann-
heim, Federal Republic of Germany). Porcine Syk (residues 1–628)lying within the same conserved Tyr-Glu-Ser-Pro motif.
was PCR amplified from the pTag/SRa-Syk vector (Couture et al.,Therefore, it is likely that Syk and Zap act directly or
1994) and fused to LDB in pBTM116. Truncated Syk plasmids Sykindirectly upstream of Vav in a pathway leading to
1–298, Syk 1–212, and Syk 213–628 were obtained by restrictionimmune receptor–induced transcription of cytokine
endonuclease digestion of the pBTM116-Syk plasmid, followed by
genes. ligation. Human Vav cDNA (residues 1–846) was PCR amplified from
On the other hand, the recruitment of PLC-g1 by acti- a pEFneo-Vav vector and fused to the GAD-encoding sequence in
pACTII. Vav 386–846, Vav 610–846, Vav 670–765, and Vav 1–610,vated Syk (Law et al., 1996) may facilitate the tyrosine
were PCR amplified from pACTII-Vav and fused to pACTII. cDNAsphosphorylation and enzymatic activation of the former,
encoding the wild-type or a Y192E-mutated version of the Lck SH2leading toproduction of secondmessengers that subse-
domain (residues 121–224) were PCR amplified from pEF-basedquently activate protein kinase C and increase the intra-
constructs (Couture et al., 1994) and fused to pACTII. The Myc
cellular calcium concentration. It is interesting that NF- epitope-tagged Vav expression vector (pEF-Vav-myc) was con-
AT stimulation by Vav overexpression, which does not structed as described (A. Munshi et al., personal communication).
The NF-AT luciferase (NF-AT-Luc) reporter plasmid was a gift fromhave a direct effect on TCR-induced calcium mobiliza-
G. Crabtree.tion, is nevertheless dependent on calcineurin (Wu et
Bacterial expression plasmids of GST fusion proteins containingal., 1995). This suggests an interaction between PLC-
the SH2 domains of Lck (GST–Lck SH2; Couture et al., 1996) or Vav
g1- (or calcium) and Vav-mediated signals. Therefore,
(GST–Vav SH2; Katzav et al., 1994) have been described. cDNAs
activated Syk family kinases seem to control at least encoding residues 161–191 of Vav (GST–Vav), or a similar peptide in
two independent signaling pathways that interact coop- which Tyr-174 has been mutated to phenylalanine (GST–Vav Y174F),
were PCR amplified from pEFneo-Vav construct and inserted in-eratively to induce activation of the IL-2 gene. The pres-
frame into the pGEX3T-1 expression vector (Pharmacia) to generateence of activated and aggregated Syk family kinases
the corresponding GST fusion proteins. All mutants were generatedwithin a membrane-localized signaling complex may
by site-directed mutagenesis of double-stranded DNA using theallowsimultaneous binding to Vav, PLC-g1, and possibly
Transformer kit (Clontech). Mutations were verified by DNA se-
other effectors (e.g., SLP-76) and facilitate their tyrosine quence analysis.
phosphorylation and functional interactions. In this re-
gard, SLP-76, a Vav SH2–interacting protein that coop-
Antibodies and Chemicalserates with it to activate the IL-2 gene, was recently
The MAb used for CD3/TCR stimulation was OKT3 (ATCC, Rockville,
shown to be phosphorylated by activated Zap (Bubeck MD), and the antibody used for BCR stimulation was a purified
Wardenburg et al., 1996). F(ab9)2 fragment of goat anti–human immunoglobulin (Cappel, West
Chester, PA). The anti-Vav MAb was from Upstate BiotechnologyThe role of Vav remains controversial (Bonnefoy-
(Lake Placid, NY), the polyclonal anti-Vav and anti-Zap antibodiesBe´rard et al., 1996). Our findings suggest that one poten-
were from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit anti-tial function of Vav is that of an adaptor protein, acting
Syk antiserum was generated as previously described (Couture etvia its phosphorylated tyrosine residues and SH2 and
al., 1996). The anti-SLP-76 MAb was provided by R. Lahesmaa and
SH3 domains (as well as other functional domains) to P. Findell (Roche Biosciences, Palo Alto, CA). The anti-PTyr MAb
recruit other signaling molecules. This action may be 4G10 was from Upstate Biotechnology. The anti-tag MAb H902 has
been described before (Couture et al., 1994). Chemicals were fromimportant for the formation of active, multisubunit sig-
Sigma, and enzymes were from GIBCO. Purified, baculovirus-naling complexes. The two SH3 domains or PH domain
derived recombinant Zap was a gift of Dr. P. Burn (Hoffman–La(or both) of Vav may connect immune receptor–
Roche, Nutley, NJ).associated PTKs and other signaling proteins to cy-
toskeletal elements. Actin cytoskeleton rearrangement
Yeast Transformation and Reporter Gene Expressionis one of the earliest events observed during activation
The yeast strain L40 (MATa, trp1, leu2, his3, LYS::lexA-HIS3,of immune cells, including mast, B, or cytotoxic T cells.
URA::lexA-lacZ) was provided by A. Vojtek (Seattle, WA) and wasThis response requires small GTPases of the Rho family,
cultured on synthetic defined drop-out yeast media lacking the ap-
which appear to be functionally linked to Vav, and are propriate amino acids obtained from BIO 101 (La Jolla, CA). Growth
also likely involved in regulating pathways leading to conditions and maintenance of the yeast strain L40 were as pre-
viously described (Guthrie and Fink, 1991). L40 was cotransformedIL-2 production in T cells. In this regard, it is tempting
with pairs of the indicated plasmids by the lithium acetate methodto speculate that Vav may bridge immune receptor–
(Gietz et al., 1992). Cotransformants were selected on Trp2, Leu2associated PTKs of the Syk and Src families to down-
plates to select for the pBTM116 and pACTII derivatives, respec-stream signaling cascades involving both Ras- and Rho-
tively. After 3 days at 308C, three colonies of each transformation
related small GTPases. were plated on Trp2, Leu2 master plates and incubated at 308C for
2 days. The transformants were then tested for histidine prototrophy
Experimental Procedures by replica plating following a 3 day incubation at 308C on Trp2,
Leu2, and His2 medium and for b-galactosidase activity using a
filter assay (Tartare-Deckert et al., 1995). Transformants were alsoPlasmids, DNA Constructs, and Mutagenesis
The yeast expression plasmids pBTM116, pGAD–Raf, pGAD–Lamin, tested for b-galactosidase activity by a quantitative assay, per-
formed essentially as described previously (Bartel and Fields, 1995).and pLexA–RasV12 (Votjek et al., 1993) were provided by A. Vojtek
(Seattle, WA). The plasmid pACTII was from Clontech (Palo Alto, In brief, a solution containing 8 mM of chlorophenol red-b-D-galacto-
pyranoside as substrate was incubated with 1 ml of yeast cell ex-CA). The plasmid encoding a hybrid between GAD and Grb2 was
provided by J. Camonis (Paris, France). The plasmids encoding GAD tract, and the increase in A574 was monitored after 30 min. Results
were expressed as units, as defined by Miller (1972).hybrids with p85, Shc, or the SH2 domains of the protein tyrosine
Immunity
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Analysis of Hybrid Protein Expression in Yeast plasmid NF-AT-Luc together with 5 mg of pEF-Vav-myc without or
Yeast cells (2 3 108) expressing LexA–Zap or LexA–Syk were lysed with 5 mg of pME18S-Syk. Similar amounts of the corresponding
as described previously (Couture et al., 1996). The lysates were empty vectors were used as controls. After 40 hr, 5 3 105 cells were
diluted 1:20 in 150 mM NaCl, 50 mM Tris–HCl [pH 7.4], 5 mM NaF, left unstimulated or were stimulated with 10 mg/ml of an anti-CD3
5 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 10 mg/ MAb (OKT3) or with 50 ng/ml of phorbol myristate acetate plus 1
ml aprotinin, 10mg/ml leupeptin, 1 mMphenylmethylsulfonyl fluoride mg/ml of ionomycin. After 6 hr at 378C, cells were lysed in 100 ml of
(PMSF); immunoprecipitated using anti-Zap or anti-Syk antibodies; 100 mM KPO4 (pH 7.8), 1 mM dithiothreitol, 0.5% Triton X-100.
and analyzed by anti-PTyr immunoblotting as described above. Aliquots of the lysates were mixed with 100 ml of assay buffer (200
mM KPO4 [pH 7.8], 10 mM ATP, 20 mM MgCl2) followed by 100 ml
Cell Lines and Stimulation of 1.0 mM luciferin. Luciferase activity was determined in triplicate
Jurkat cells (E6-1; ATCC) or simian virus 40 T antigen (TAg)- and expressed as arbitrary units (AU).
transfected Jurkat (Jurkat-TAg) cells (obtained from G. Crabtree)
were cultured in RPMI 1640 medium, 10% fetal calf serum (FCS), 2 Acknowledgments
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Cells were centrifuged to remove the supernatant and lysed in 1 ml
lysis buffer (1% Nonidet P-40 [NP-40] in buffer A) for 20 min on ice. References
Nuclei were pelleted by centrifugation for 15 min at 16,000 3 g at
48C. For GST precipitations, lysates were incubated with 5 mg of Arpaia, E., Shahar, M., Dadi, H., Cohen, A., and Roifman, C.M. (1994).
the indicated GST fusion protein for 4 hr at 48C, followed by incuba- Defective T cell receptor signaling and CD81 thymic selection in
tion with glutathione–Sepharose 4B beads (Pharmacia) for 1 hr. humans lacking Zap-70 kinase. Cell 76, 947–958.
Samples were washed four times in RIPA buffer (1% NP-40, 0.5% Ausubel, F.M., Brent, R., Kingston,R.E., Moore, D.D., Seidman, J.G.,
deoxycholate, 0.1% sodium dodecyl sulfate [SDS] in buffer A). Smith, J.A., and Struhl, K. (1992). Current Protocols in Molecular
For immunoprecipitations, lysates were incubated with optimal Biology (New York: John Wiley & Sons).
concentrations of the indicated antibodies for 4 hr at 48C, followed
Bartel, P.L., and Fields, S. (1995). Analyzing protein-protein interac-by incubation with anti–mouse IgG-conjugated agarose beads for
tions using two-hybrid system. Meth. Enzymol. 254, 241–263.1 hr. Samples were washed three times in RIPA buffer. Precipitates
were dissolved in SDS sample buffer, resolved by 10% SDS–PAGE, Bonnefoy-Be´rard, N., Munshi, A., Yron, I., Wu, S., Collins, T.L., Deck-
and analyzed by immunoblotting as described below. ert, M., Shalom-Barak, T., Giampa, L., Herbert, E., Hernandez, J.,
For in vitro kinase assay, immunoprecipitates or recombinant pro- Meller, N., Couture, C., and Altman, A. (1996). Vav: function and
teins were incubated in 40 ml of 50 mM HEPES (pH 7.4), 10 mM regulation in hematopoietic cell signaling. Stem Cells 14, 250–268.
MnCl2, 10 mM MgCl2, 0.1% NP40, 10 mCi of [g-32P]ATP (3000 Ci/ Brunati, A.M., Donella Deana, A., Ruzzene, M., Marin, O., and Pinna,
mmol; New England Nuclear, Boston, MA) plus 5 mg of the indicated L.A. (1995). Site specificity of p72syk protein tyrosine kinase: efficient
GST fusion proteins for 15 min at 308C with gentle agitation. Reac- phosphorylation of motifs recognized by Src homology 2 domains
tions were stopped by the addition of sample buffer, boiled at 958C of the Src family. FEBS Lett. 367, 149–152.
for 5 min, and analyzed by SDS–PAGE and autoradiography.
BubeckWardenburg, J., Fu, C., Jackman, J.K., Flotow,H., Wilkinson,
S.E., Williams, D.H., Johnson, R., Kong, G., Chan, A.C., and Findell,Immunoblotting and Far Western Blotting
P.R. (1996). Phosphorylation of SLP-76 by the ZAP-70 protein-tyro-SDS–PAGE-resolved samples were transferred to nitrocellulose
sine kinase is required for T-cell receptor function. J. Biol. Chem.membranes (0.4 mm pore size; Bio-Rad). The membranes were
271, 19641–19644.blocked with 5% dry milk dissolved in TBST (25 mM Tris–HCl [pH
7.5], 125 mM NaCl, 0.1% Tween 20) for 16 hr at 48C. The membranes Bustelo, X.R., Ledbetter, J.A., and Barbacid, M. (1992). Product of
were then incubated for 2 hr in blocking buffer containing 1 mg/ml vav proto-oncogene defines a new class of tyrosine protein kinase
of the indicated antibodies. The membranes were washed three substrates. Nature 356, 68–71.
times for 10 min in TBST, incubated with horseradish peroxidase Cambier, J.C. (1995). New nomenclature for the Reth motif (or ARH1/
(HRP)-conjugated donkey anti–rabbit or sheep anti–mouse IgG anti-
TAM/ARAM/YXXL). Immunol. Today 16, 110.
body (1:2000; Amersham) for 30 min at room temperature, washed
Chan, A.C., Kadlecek, T.A., Elder, M.E., Filipovich, A.H., Kuo, W.-L.,three times in TBST, and developed using an enhanced chemilumi-
Iwashima, M., Parslow, T.G., andWeiss, A. (1994). ZAP-70 deficiencynescence kit (Amersham) following the instructions of the manufac-
in an autosomal recessive form of severe combined immunodefi-turer.
ciency. Science 264, 1599–1601.For Far Western blotting, the blocked membranes were incubated
overnight with 10 mg/ml of the indicated GST fusion proteins in 5% Cheng, A.M., Rowley, B., Pao, W., Hayday, A., Bolen, J.B., and
milk in TBST, washed three times with TBST, incubated with an Pawson, T. (1995). Syk tyrosine kinase required for mouse viability
anti-GST MAb (0.1 mg/ml; Santa Cruz) for 1 hr at room temperature, and B-cell development. Nature 378, 303–306.
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